Skip to main content
Clinical Trials/CTRI/2024/10/074659
CTRI/2024/10/074659Not yet recruitingPhase 2

Randomised trial comparing the efficacy of pre-operative Nebulised Dexmedetomidine with Nebulised Lignocaine in attenuation of hemodynamic pressor response to laryngoscopy and nasotracheal intubation-A Phase II study

Cancer Institute WIA1 site in 1 country80 target enrollmentStarted: October 15, 2024Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
80
Locations
1
Primary Endpoint
Comparison of the efficacy of nebulised dexmedetomidine with nebulised lignocaine on attenuation of systolic blood pressure in patients undergoing laryngoscopy and nasotracheal intubation

Study Overview

Brief Summary

Endotracheal intubation is  a highly stimulating procedure associated  with a surge in catecholamine levels and significant hemodynamic  alterations which may adversely impact postoperative outcomes, especially in patients with multiple comorbidities.Nasotracheal intubation has been found to be more hemodynamic changes due to the involvemnt of highly sensitive structures. Multiple drugs have been used but no ideal drug has been identified. Nebulised dexmedetomidine offers a novel solution to using its properties in attenuating the hemodynamic changes without any of its side effects. Nebulised lignocaine also has been studied extensively wrt to its effect on blunting the intubation response. However, these drugs have not been compared for their effects on nasotracheal intubation. It is being hypothesised that nebulised dexmedetomidine may be more effective than nebulised lignocaine based on previous research.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 85.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Adults, both male and female, aged above 18years, coming for surgery under general anesthesia needing nasotracheal intubation, classified under ASA 1,2 status.

Exclusion Criteria

  • presence of heart block, asa 3-4, drug allergy to propofool, egg, cardiac dysfunction.

Outcomes

Primary Outcomes

Comparison of the efficacy of nebulised dexmedetomidine with nebulised lignocaine on attenuation of systolic blood pressure in patients undergoing laryngoscopy and nasotracheal intubation

Time Frame: before drug administration, induction and 10 minutes after nasotracheal intubation

Secondary Outcomes

  • the effect of nebulised dexmed/lignocaine on heart rate, BP, sedation score, need for additional drugs to maintain hemoodynamic stability, the mean of the pre induction and post intubation HR, Mean arterial pressure and diastolic bp shall be compared, mean propofol requirement between the 2 groups shall be compared(pre drug, induction and 10 minutes post intubation)

Investigators

Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr.Pritha Raj

cancer institute

Study Sites (1)

Loading locations...

Similar Trials